Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels.
about
Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patientsRisperidone treatment of drug-related psychosis in patients with parkinsonismMechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part IIAtypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.Psychotic symptoms in Parkinson's disease: pathophysiology and management.Combating psychosis in Parkinson's disease patients: the use of antipsychotic drugs.Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation.Risperidone and Parkinson's disease.Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade.Pharmacokinetics and time-course of D(2) receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients.
P2860
Q24633061-1DDE246C-57A7-4A66-90C8-D4887753D487Q28375634-59DB0666-AD44-4F0C-978D-30C44076FE28Q33612521-01417E23-B677-4C61-B875-F90FAF1E4593Q33884378-7E14912D-DEE0-4C38-8A05-A53F0AE8A3A6Q35779329-834444DB-501C-443B-A526-BB6F58B8A159Q36425995-1D84C899-3D4C-431E-B913-521999CEF753Q37809494-ED9E5858-1414-4FC0-9B5D-B8F085C523C7Q43880984-1A7CD5A8-F110-47EC-BDE3-EC1EE7AF10EEQ45094155-198251B1-5AF8-45AD-8CF5-7EE18AF4E995Q46727005-B052E538-5D23-4437-9D3A-7349FDD7B746
P2860
Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels.
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Extrapyramidal side effects wi ...... D2 receptor occupancy levels.
@ast
Extrapyramidal side effects wi ...... D2 receptor occupancy levels.
@en
Extrapyramidal side effects wi ...... D2 receptor occupancy levels.
@nl
type
label
Extrapyramidal side effects wi ...... D2 receptor occupancy levels.
@ast
Extrapyramidal side effects wi ...... D2 receptor occupancy levels.
@en
Extrapyramidal side effects wi ...... D2 receptor occupancy levels.
@nl
prefLabel
Extrapyramidal side effects wi ...... D2 receptor occupancy levels.
@ast
Extrapyramidal side effects wi ...... D2 receptor occupancy levels.
@en
Extrapyramidal side effects wi ...... D2 receptor occupancy levels.
@nl
P2093
P1433
P1476
Extrapyramidal side effects wi ...... D2 receptor occupancy levels.
@en
P2093
P304
P356
10.1016/S0925-4927(97)00023-1
P407
P577
1997-09-01T00:00:00Z